Heyholder
‹ Activism Filings

SLSBio(Specialty Lab Solution Bio) Co., Ltd Q3 revenue KRW 1.7 billion, operating loss KRW 0.8 billion

SLSBio(Specialty Lab Solution Bio) Co., Ltd· Periodic Report

AI summary · Not investment advice

SLS Bio sold KRW 1.7 billion in Q3 and lost KRW 0.8 billion from its main business, with sales up 459.7% from a year earlier and 27.8% from the prior quarter.

Operating profit · 3 months

KRW -810.5 million

Key facts

Revenue (3 months)
KRW 1.7 billion
Net income (3 months)
KRW -819.1 million
Period
Q3 (cumulative 2026.01.01 ~ 2026.09.30)
Revenue (prior-year 3 months)
KRW 295.7 million
Revenue (year to date)
KRW 3.9 billion
Operating profit (prior-year 3 months)
KRW -1.8 billionOperating loss
Operating profit (year to date)
KRW -2.7 billionOperating loss
Net income (prior-year 3 months)
KRW -1.9 billionNet loss
Net income (year to date)
KRW -2.7 billionNet loss

Commentary

AI commentary · Not investment advice

What happened

SLS Bio filed its quarterly report for the third quarter on a standalone basis. Sales for the 3 months were KRW 1.66 billion (KRW 1,655,174,969). That compares with KRW 295.7 million in the same 3 months a year earlier. Sales rose 459.7% from a year earlier and 27.8% from the previous quarter.

In the company's terms

Operating profit (profit from the core business) for the 3 months was a loss of KRW 810.5 million. A year earlier it was a loss of KRW 1.80 billion. Net income (final profit after taxes and all other items) for the 3 months was a loss of KRW 819.1 million. A year earlier it was a loss of KRW 1.87 billion.

What changes for shareholders

For the year so far (January 1 to September 30), sales were KRW 3.91 billion. Operating loss was KRW 2.66 billion. Net loss was KRW 2.73 billion.

Comments

No comments yet

Comments from shareholders will appear here.